Reward Deficiency Syndrome (RDS)
What is Reward Deficiency Syndrome (RDS)?
Reward Deficiency Syndrome (RDS) is a term used to describe a cluster of behaviors and neurochemical imbalances resulting from dysfunction in the brain’s reward circuitry—particularly the dopaminergic system. People with RDS have a reduced ability to experience pleasure or satisfaction from normally rewarding stimuli (such as food, relationships, or achievement), leading them to seek out excessive stimulation through risky, compulsive, or addictive behaviors.
This dysfunction is often rooted in genetic predispositions that impair dopamine signaling, the neurotransmitter most associated with motivation, pleasure, and reward.
Four Key Behavioral Domains of RDS
The Link Between RDS and Addiction
Addiction is widely considered a symptom or outcome of RDS. Because of impaired dopamine function, individuals with RDS are more vulnerable to developing addictive behaviors. Repeated engagement with substances or compulsive actions temporarily boosts dopamine levels, reinforcing the cycle of dependency. Over time, this can worsen dopamine sensitivity, further deepening the deficiency.
RDS provides a unifying framework for understanding a broad spectrum of addictive and compulsive behaviors. The GARS test bridges cutting-edge genetic science with clinical practice, offering a path toward precision behavioral health. By identifying neurogenetic vulnerabilities, clinicians can better manage, treat, and even prevent the debilitating effects of RDS and related disorders.
FAQs
Reward Deficiency Syndrome is a condition where the brain doesn’t make or use enough dopamine, a chemical that helps you feel happy, focused, and motivated. When dopamine levels are too low, people may feel bored, stressed, or unhappy more often. This can lead to behaviors that temporarily boost dopamine, like overeating, using drugs, or taking risky actions. Scientists call these “reward-seeking” behaviors.
Your genes help decide how your brain works, including how it makes and uses dopamine. About half of your risk for RDS comes from your DNA. The other half comes from your environment, things like stress, family life, or peer influence.
We accept payment via credit card (Visa, MasterCard, American Express), PayPal, and bank transfer.
Predict IQ powered by GARS is the first patented genetic test that helps find out if you have DNA variations that raise your risk for RDS. These variations, called alleles, are found in certain genes related to the brain’s reward system.
It uses a simple cheek swab to find variations in dopamine-related genes like DRD2, COMT, MAOA, and others. These genes affect how well your brain uses dopamine. If your test shows several “risk variants,” you may be more likely to develop addictive or compulsive behaviors.
Knowing your genetic risk gives you the power to make smart choices about your life. If you know you’re more likely to struggle with impulse control or addiction, you can take steps to avoid triggers, seek support, or even use special nutritional support (like Synapta) that’s designed to help balance dopamine in your brain. It’s about using science to make better decisions and live a healthier, more focused life.
This testing method is backed by over 500 scientific papers and decades of research in psychiatry, genetics, and addiction medicine. The Predict IQ platform is used in behavioral health, justice systems, and addiction treatment to create personalized care plans based on genetics.
Predict IQ checks your DNA for genetic risk factors related to dopamine function. Your score is based on how many known “risk genes” you have.
Knowing your genetic risks can help you make better decisions, avoid harmful behaviors, and take steps to improve brain health, especially with guidance from behavioral health professionals and personalized support like Synapta+.